BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kosa RE, Lazzaro S, Bi YA, Tierney B, Gates D, Modi S, Costales C, Rodrigues AD, Tremaine LM, Varma MV. Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey. Drug Metab Dispos 2018;46:1179-89. [PMID: 29880631 DOI: 10.1124/dmd.118.081794] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Shang H, Sun Y, Wang Z, Zhou Y, Yang H, Ci X, Cui T, Xia Y, Gu Y, Liao M, Li Q, Si D, Liu C. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1. J Ethnopharmacol 2022;:115006. [PMID: 35051604 DOI: 10.1016/j.jep.2022.115006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wiebe ST, Giessmann T, Hohl K, Schmidt-Gerets S, Hauel E, Jambrecina A, Bader K, Ishiguro N, Taub ME, Sharma A, Ebner T, Mikus G, Fromm MF, Müller F, Stopfer P. Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. Clin Pharmacokinet 2020;59:1627-39. [PMID: 32504272 DOI: 10.1007/s40262-020-00907-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 Sharma S, Prasad B. Meta-Analysis of Food Effect on Oral Absorption of Efflux Transporter Substrate Drugs: Does Delayed Gastric Emptying Influence Drug Transport Kinetics? Pharmaceutics 2021;13:1035. [PMID: 34371727 DOI: 10.3390/pharmaceutics13071035] [Reference Citation Analysis]
4 Costales C, Lin J, Kimoto E, Yamazaki S, Gosset JR, Rodrigues AD, Lazzaro S, West MA, West M, Varma MVS. Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modeling. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34164937 DOI: 10.1002/psp4.12672] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Jala A, Ponneganti S, Vishnubhatla DS, Bhuvanam G, Mekala PR, Varghese B, Radhakrishnanand P, Adela R, Murty US, Borkar RM. Transporter-mediated drug-drug interactions: advancement in models, analytical tools, and regulatory perspective. Drug Metab Rev 2021;:1-36. [PMID: 33980079 DOI: 10.1080/03602532.2021.1928687] [Reference Citation Analysis]
6 Cheng Y, Liang X, Hao J, Niu C, Lai Y. Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys. Clin Transl Sci 2021;14:1924-34. [PMID: 34058067 DOI: 10.1111/cts.13047] [Reference Citation Analysis]
7 Eng H, Bi YA, West MA, Ryu S, Yamaguchi E, Kosa RE, Tess DA, Griffith DA, Litchfield J, Kalgutkar AS, Varma MVS. Organic Anion-Transporting Polypeptide 1B1/1B3-Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro-In Vivo Evaluation in Cynomolgus Monkey. J Pharmacol Exp Ther 2021;377:169-80. [PMID: 33509903 DOI: 10.1124/jpet.120.000457] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ronaldson PT, Brzica H, Abdullahi W, Reilly BG, Davis TP. Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor-β Signaling in Human Endothelial Cells. J Pharmacol Exp Ther 2021;376:148-60. [PMID: 33168642 DOI: 10.1124/jpet.120.000267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Tess DA, Eng H, Kalgutkar AS, Litchfield J, Edmonds DJ, Griffith DA, Varma MVS. Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs. J Med Chem 2020;63:11831-44. [PMID: 32985885 DOI: 10.1021/acs.jmedchem.0c01033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Guo C, Brouwer KR, Stewart PW, Mosley C, Brouwer KLR. Probe Cocktail to Assess Transporter Function in Sandwich-Cultured Human Hepatocytes. J Pharm Pharm Sci 2019;22:567-75. [PMID: 31804919 DOI: 10.18433/jpps30706] [Reference Citation Analysis]
11 Zhang Y, Holenarsipur VK, Kandoussi H, Zeng J, Mariappan TT, Sinz M, Shen H. Detection of Weak Organic Anion–Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans. Drug Metab Dispos 2020;48:841-8. [DOI: 10.1124/dmd.120.000076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Y, Chen C, Chen SJ, Chen XQ, Shuster DJ, Puszczalo PD, Fancher RM, Yang Z, Sinz M, Shen H. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression. J Pharmacol Exp Ther 2020;375:139-51. [PMID: 32719071 DOI: 10.1124/jpet.120.000139] [Reference Citation Analysis]
13 Gu X, Wang L, Gan J, Fancher RM, Tian Y, Hong Y, Lai Y, Sinz M, Shen H. Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition. Drug Metab Dispos 2020;48:724-34. [DOI: 10.1124/dmd.120.090670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nakaoka T, Uetake Y, Kaneko KI, Niwa T, Ochiai H, Irie S, Suezaki Y, Otsuka N, Hayashinaka E, Wada Y, Cui Y, Maeda K, Kusuhara H, Sugiyama Y, Hosoya T, Watanabe Y. Practical Synthesis of [18F]Pitavastatin and Evaluation of Hepatobiliary Transport Activity in Rats by Positron Emission Tomography. Mol Pharm 2020;17:1884-98. [PMID: 32271581 DOI: 10.1021/acs.molpharmaceut.9b01284] [Reference Citation Analysis]
15 Zou L, Pottel J, Khuri N, Ngo HX, Ni Z, Tsakalozou E, Warren MS, Huang Y, Shoichet BK, Giacomini KM. Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP. Mol Pharm 2020;17:748-56. [PMID: 31990564 DOI: 10.1021/acs.molpharmaceut.9b00658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Lu C, Di L. In vitro and in vivo methods to assess pharmacokinetic drug– drug interactions in drug discovery and development. Biopharm Drug Dispos 2020;41:3-31. [DOI: 10.1002/bdd.2212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
17 Maeda K. Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions. Drug Metab Pharmacokinet 2020;35:76-88. [PMID: 31948854 DOI: 10.1016/j.dmpk.2019.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Taskar KS, Pilla Reddy V, Burt H, Posada MM, Varma M, Zheng M, Ullah M, Emami Riedmaier A, Umehara KI, Snoeys J, Nakakariya M, Chu X, Beneton M, Chen Y, Huth F, Narayanan R, Mukherjee D, Dixit V, Sugiyama Y, Neuhoff S. Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations. Clin Pharmacol Ther 2020;107:1082-115. [PMID: 31628859 DOI: 10.1002/cpt.1693] [Cited by in Crossref: 27] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
19 Liang RF, Ge WJ, Song XM, Zhang JP, Cui WF, Zhang SF, Li GS. Involvement of organic anion-transporting polypeptides and organic cation transporter in the hepatic uptake of jatrorrhizine. Xenobiotica 2020;50:479-87. [PMID: 31368836 DOI: 10.1080/00498254.2019.1651921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Taniguchi T, Ashizawa N, Matsumoto K, Saito R, Motoki K, Sakai M, Chikamatsu N, Hagihara C, Hashiba M, Iwanaga T. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor. J Pharmacol Exp Ther 2019;371:162-70. [DOI: 10.1124/jpet.119.259341] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
21 Zhang Y, Panfen E, Fancher M, Sinz M, Marathe P, Shen H. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate. Mol Pharmaceutics 2019;16:2342-53. [DOI: 10.1021/acs.molpharmaceut.8b01226] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
22 Bi YA, Costales C, Mathialagan S, West M, Eatemadpour S, Lazzaro S, Tylaska L, Scialis R, Zhang H, Umland J, Kimoto E, Tess DA, Feng B, Tremaine LM, Varma MVS, Rodrigues AD. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes. J Pharmacol Exp Ther 2019;370:72-83. [PMID: 30975793 DOI: 10.1124/jpet.119.257600] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
23 Yang C, Liu Q, Li G, Meng X, Liu B. Effect of P-glycoprotein regulation on cadmium exhaustion from Crassostrea gigas. Mar Pollut Bull 2019;141:307-12. [PMID: 30955738 DOI: 10.1016/j.marpolbul.2019.02.042] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Matin B, Sherbini AA, Alam N, Harmatz JS, Greenblatt DJ. Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid. J Pharm Pharmacol 2019;71:371-8. [PMID: 30417385 DOI: 10.1111/jphp.13037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]